All GLP-1 receptor agonists cause similar modest heart rate increases of approximately 24 beats per minute on average, including liraglutide, semaglutide, dulaglutide, and tirzepatide
Scientific Note: Although there is much anecdotal evidence supporting the effectiveness of lipotropic injections alone, the scientific community has not fully validated the clinical effectiveness
The MHRA has approved various GLP-1 formulations with different dosing schedulessome require daily injections whilst others are administered weekly or taken orally
Our team has reviewed this pattern across hundreds of research orders
Moreover, whether the exosomes continuously secreted by the engineered cells, as a delivery vector themselves, will transfer the genetic modification effects laterally to distant tissue cells and thereby cause toxicity, is also an urgent issue that needs to be deeply clarified as a safety concern [168]